The impact of “4 + 7” volume-based drug procurement on the volume, expenditures, and daily costs of antihypertensive drugs in Shenzhen, China: an interrupted time series analysis

BACKGROUND: In 2019, Chinese government launched a nationwide volume-based drug procurement aiming at reducing drug prices and saving drug costs through economies of scale, which aroused widespread attention. The first round of the policy pilot was implemented in 4 municipalities and 7 sub-provincia...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Ying, Tong, Ruiwen, Yin, Shicheng, Mao, Lining, Xu, Luxinyi, Hao, Siyu, Mao, Zongfu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8620621/
https://www.ncbi.nlm.nih.gov/pubmed/34823516
http://dx.doi.org/10.1186/s12913-021-07143-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8620621/
https://www.ncbi.nlm.nih.gov/pubmed/34823516
http://dx.doi.org/10.1186/s12913-021-07143-3

Ejemplares similares